New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

For more information about NeuroStar TMS Therapy, please visit NeuroStar.com. NeuroStar Advanced Therapy is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication has not helped. Neuronetics Contact:Investors:Mike Vallie or Mark KlausnerICR Healthcare443-213-0499[email protected] Media:EvolveMKD646.517.4220[email protected] References: New York Medicaid TMS coverage: https://www.health.ny.gov/health_care/medicaid/program/update/2025/no07_2025-07.htm#TMS NIMH https://www.nimh.nih.gov/health/statistics/major-depression.shtml, accessed 4/29/2024. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. Clinical Outcomes in a Large Registry of Patients with Major Depressive Disorder Treated with Transcranial Magnetic Stimulation.